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Mice  primed  with  influenza  viruses  generate  at  least  two  categories  of 
cytotoxic T  cells (1,  2).  One component is highly cross-reactive for all type A 
influenza viruses (1-4), and may be specific for the shared internal matrix (M) 1 
protein which is now known to be expressed on cell surface (5-7). The second set 
of T  cells reacts only with the virus used for immunization and is probably 
recognizing determinents  on  the  hemagglutinin  (H)  molecule  (8,  9).  Other 
virus-immune T-cell responses have been subdivided in quite a  different way, 
on the basis of associating various specificities with the H-2K and H-2D genetic 
regions (10). Clonal analysis of this type has not been attempted previously for 
influenza,  principally because we lacked a  sufficient range of H-2  different 
target cells which could be suitably infected with the virus. Such experiments 
are especially worth pursuing for the T-cell subset which is cross-reactive for all 
type A influenza viruses. The biological specificity and relevance of this effector 
population have been seriously questioned (8) though, for most investigators (2- 
4, 9), these lymphocytes apparently comprise the majority of the host response. 
The  development of SV40-transformed tumor  cells from  H-2  recombinant 
mice has now enabled us to map influenza-immune T-cell responses within the 
H-2 gene complex. Two new points emerge. The first is that the H-2K  b allele is 
associated with a total failure in the generation of influenza-immune effector T 
cells.  The second is the existence of a  possible Ir gene effect that modulates 
cytotoxic T-cell responses to both influenza and vaccinia viruses at H-2D  b. 
Materials and Methods 
Mice.  The CBA/J and B10.Br  (kkkkkk),  C57BL/6J  (B6) and C57BL/10J  (B10) (bbbbbb),  A/J 
and  B10.A  (kkkddd),  B10.D2 (dddddd),  B10.A(SR)  (bbbddd)  and  the  various  F1  mice  were 
purchased from The Jackson Laboratory, Bar Harbor, Maine. The C3H.OH  (dddddk) mice and 
some of the B10 recombinant strains,  including the B10.A(2R) (kkkddb), B10.A(3R) (bbbddd), 
B10.A(4R) (kkbbbb), B10.A(5R) and B10.HTT (ssskkd)  were either  bred  at  the  Wistar Institute  or 
provided by  Dr. G. M. Shearer  of  the  National  Cancer Institute.  The BALB/c mice  were  purchased 
from the Institute  for  Cancer Research, Fox Chase, Philadelphia. 
* Supported by U. S. Public Health Service Grants CA 20833 and AI 14162. 
1  Abbreviations  used  in  this  paper:  H,  influenza  virus  hemagglutinin  antigen;  HA,  virus 
hemagglutinating unit; H-2, mouse m~dor histocompatibility complex; LU, lytic unit; M, influenza 
virus matrix protein; N, influenza virus neuraminidase antigen; PFU, virus plaque-forming unit; 
SV40, simian virus 40. 
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Target Cells.  The L cell (C3H, kkkkkk), P815 (DBA/2, dddddd), MC57G (B6, bbbbbb) and NA 
(A/J, kkkddd) target ceils have been described previously (1, 11).  Cell lines were established by 
transforming C3H.OH, BI0.A(2R), B16.A(4R) and B10.A(5R) kidney cells with SV40 virus. These 
cells are referred to as C3H.OHSV, 2RSV, 4RSV, and 5RSV. 
Viruses.  The preparation and source of the influenza A virus strains PR8 [A/Puerto Rico/8/34 
(HON1)]  and HK  [A/Hong Kong/×  31  (H3N2)]  and the vaccinia virus  (WR isolate) have been 
described previously  (1,  2,  12).  Mice were dosed  intraperitoneally with from  120-300  HA  U  of 
influenza virus, the interval between primary and secondary challenge ranging from 9 to 50 days. 
Target cells were incubated for I h with 6-15 HA U per 10  ~ cells. The dose of vaccinia virus given 
intravenously to mice was 5 ×  108 plaque-forming units (PFU), and target cells were exposed to 1 
PFU per cell. 
Cytotoxic Assays.  Alloreactive T cells were generated in vitro by using a standard technique, 
and effector function was determined in a conventional 6 h 5~Cr release assay (13).  The influenza 
and  vaccinia-immune T-cell  assays  have also  been described previously  in detail  (I,  12),  the 
lymphocytes and 51Cr-labeled targets being incubated togther for 12-14 h  at 37°C.  Results  are 
expressed as specific 51Cr release relative to incubation in medium alone (i), or as lytic unit (LU) 
values calculated by the formula: 
target cells per well ×  1,000 
spleen cells causing 33% specific 5~Cr release 
The number of spleen cells causing 33% specific s~Cr release was determined by graphing values 
for four effector:target ratios (14), usually ranging from 12:1 to I00:I. 
Results 
H-2 Restriction of Cross-Reactive Influenza-Immune T Cells and Absence of 
Response at H-2K b.  Mice were first primed with one influenza A  virus,  and 
memory  T-cell populations  were then  challenged  with a  heterologous  type A 
virus.  This procedure has been shown previously  to stimulate  only the cross- 
reactive T-cell subset (1, 15). Effector lymphocytes did not discriminate between 
target  cells  infected  with  serologically  different  influenza  A  viruses  (PRS, 
HON1  and  HK,  H3N2),  but  clear  evidence  was  found  for  H-2  restriction 
operating  at  the  D  locus  (Table  I).  The  surprise  was,  however,  that  the 
B10.A(5R) mice generate a strong response associated with H-2D  d, but not with 
H-2K  b. 
TABLE  I 
H-2 Restriction of Cytotoxic T-Cell Activity which is Cross-Reactive for Different 




K  D 
Specific 51Cr release (100:1) 
L Cells (kk)  P815 (dd)  MC57G (bb) 
PR8*  HK  N  PR8  HK  N  PR8  HK  N 
% 
C3H.OH  d  k  30  37  1  45  45  0  0  0  0 
B10.HTT  s  d  3  0  0  35  29  0  2  3  '  0 
B10.A(5R)  b  d  0  0  0  65  61  0  2  7  0 
B6  b  b  1  0  0  5  5  0  39  28  0 
(BALB/c x  B6)F1  d/b  d/b  6  6  1  50  45  0  26  23  0 
(A/J ×  B6) F1  k/b  d/b  68  72  0  54  47  2  35  45  0 
* Mice were primed with PR8 (HONI), challenged 9 days later  with HK (H3N2), and killed  after 
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TABLE II 
Absence of Influenza-Specific T Cells at H-2K  b and Defective Responsiveness (but not 
Antigenicity) at H-2D b in Recombinant Mice 
Exp.  Mouse strain* 
H-2 
K  D 
LU Values for HK (H3N2)-infected target cells$ 
L Cell  MC57G  P815  2RSV  5RSV  NA 
B6  b  b  <1  32  <1  25  <1  <1 
B10.Br  k  k  1,000  <1  <1  100  2  330 
B10.HTT  s  d  <1  <1  40  <1  32  50 
B10.A(4R)  k  b  500  2  <1  100  <1  250 
BALB/c  d  d  <1  <1  32  <1  16  32 
(BALB/c × B6) F1  <1  50  100  50  63  100 
L Cell  MC57G  C3H.OHSV  2RSV  5RSV 
B6  b  b  <1  25  <1  40  <1 
B10.Br  k  k  1,000  <1  16  200  <1 
B10.D2  d  d  <1  <1  16  <1  20 
B10.A(2R)  k  b  66  <1  <1  40  <1 
B10.A(3R)  b  d  <1  <1  <1  <1  125 
B10.A(5R)  b  d  <1  <1  <1  <1  50 
L Cell  MC57G  2RSV  NA 
B10  b  b  <1  32  32  <1 
B10.Br  k  k  32  <1  16  13 
B10.A(2R)  k  b  40  <1  32  32 
B10.A(SR)  b  d  <1  <1  <1  20 
* Mice in the top two experiments were first primed with PR8  (HON1),  challenged with HK 
(H3N2)  1 mo later, and sampled after an additional 4 days. The order of virus administration 
was reversed in the third experiment. 
$ L cell, Kk-Dk;  MC57G, Kb-Dd; P815, Kd-Dd; 2RSV, Kk-Db; 5RSV, Kb-Dd; NA, Kk-Dd; C3H.OH,  K d- 
D  k  . 
Both the  validity of the H-2  restriction phenomenon  and  the existence of a 
defect  at  H-2K  b  were  confirmed  in  further  experiments  (Table  II).  Neither 
B10.A(5R)  nor  B10.A(3R)  mice  (which  differ  in  the  I-J  region)  generate 
influenza-immune  T  cells  capable  of  lysing  the  MC57G  (H-2  b)  target  cell. 
Furthermore,  lymphocytes from B6 and B10 mice do not interact with influenza- 
infected B10.A(5R) cells. There is thus an apparent  failure of both response and 
recognition at H-2K  b, even though the target cells express the H-2K  b alloantigen 
(Table III). 
Differential Response to Influenza Virus at H-2D b.  The second observation 
of interest  is that  B10.A(2R)  and B10.A(4R) mice do not generate  a  significant 
influenza-immune  T-cell response  at  H-2D  b,  although  there  is no  defect at  H- 
2K  k (MC57G and L cell targets, Table II). This differs from the situation for the 
B10.A(SR), however, as effector T cells from H-2 b mice are strongly cytotoxic for 
the B10.A(2R) target cell (Table II). A  cold-target competitive-inhibition exper- 
iment further established that suitable antigenic determinants  are expressed at 
H-2D  b on the virus-infected  MC57G  (H-2  b) target,  which are recognized by B6 
influenza-immune  T  cells  (Fig.  1).  Thus,  there  is a  failure of responsiveness 
when H-2D  b is associated with H-2K  k and with I-A k, but not with H-2K  b and I- 
A b  . P.  C.  DOHERTY,  W.  E.  BIDDISON,  J.  R.  BENNINK,  AND  B.  B.  KNOWLES 
TABLE  IH 
Detection of  H-2K b and H-2D b Antigens by Alloreactive T  Cells 
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Effector  population 
Stimulator  Responder 
Ratio* 
Specific slCr release 
% 
MC57G  5RSV 
Kb.D  b  Kb.D  d 
P815 
Kd.D  d 
B10.A(5R)  B10.A  20:1  65  26  0 
(Kb-D  d)  (Kk-D  d)  5:1  35  14  0 
B10.A(2R)  B10.A  20:1  70  0  10 
(Kk-D  b)  (Kd-D  d)  5:1  38  0  3 
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INHIBITOR  CELL: TARGET  CELL 
FIG.  1.  Secondary B6 (Kb-D  b) and (BALB/c x  B6) F1 (dd x  bb) influenza-immune T cells 
were generated by priming with PR8 influenza virus and challenging 6 wk later with the 
HK  influenza virus.  Effector spleen populations were tested 4 days later in a  cold-target 
competitive inhibition assay  (1,  2).  (a) B6 effecters assayed on slCr-labeled HK-infected 
MC57G (bb) target cells (100:1).  (b) (BALB/c x  B6) F1 effectors assayed on 51Cr-labeled HK- 
infected NA (kd) target cells (75:1).  Competitor cells were uninfected (0, m) or HK-infected 
(O,  [~) 2RSV (m, D)  (kb), and 5RSV (0,  O) (bd).  (9 indicates lysis in the absence of any 
competitor cells.  The obvious inhibition of cytotoxicity on MC57G cells caused by virus- 
infected 2RSV, but not 5RSV, competitors indicate that this H-2 b target is lysed by virus- 
immune T-cell populations recognizing H-2D  b. Similarly, both 5RSV and NA are shown to 
be recognized by cytotoxic T cells operating at H-2D  d, a point which is necessary for control 
purposes but is already established in Tables I and II. 538  H-2-RELATED  LOW  RESPONSIVENESS  OF  VIRUS-IMMUNE  T  CELLS 
TABLE IV 
Vaccinia-Immune T-Cell  Response is  Found Reciprocally  for  H-2K  #  but not  for  H-2D  b 
Exp.  Mouse strain* 
H-2 Type  LU Values  for  vaccinia-infected  targets 
L Cell  MC57G  P815  2RSV  4RSV  5RSV 
K  D 
kk  bb  dd  kb  kb  bd 
B10  b  b  3  50  2  20  -  50 
B10.Br  k  k  200  2  <1  125  -  <1 
B10.D2  d  d  3  2  40  3  -  50 
B10.A(2R)  k  b  170  <1  <1  170  -  <1 
B10.A(4R)  k  b  125  2  <1  250  -  2 
B10.A(5R)  b  d  2  50  8  3  -  100 
2  B10.A(2R)  k  b  40  <1  -  20  20  <1 
B10.A(5R)  b  d  <1  13  -  <1  <1  25 
* Mice were primed i.v. with vaecinia virus 6 days previously. 
Vaccinia  Virus  and  the  H-2 b Haplotype.  Control experiments were done 
with vaccinia virus to determine whether MC57G and the SV40-transformed 
B10.A(5R) cell line could act as targets at H-2K  b for any virus system. A strong 
vaccinia-immune cytotoxic T-cell response was seen at both H-2K  b and H-2D  b in 
the B10  strain  (Table IV).  However, an identical defect to that found in the 
influenza model was observed for both the B10.A(2R) and B10.A(4R). Little, if 
any,  effector function was  recognized  for  H-2D  b  in  these  H-2  recombinant 
strains, though there was no failure in expression of virus-induced antigenic 
changes associated with H-2D b in the B10.A(2R)  target. 
Two  possible  explanations  were  considered  for  the  K,  /-A-related  defect 
modifying the response at H-2D  b. The first is that genes in the K-end in some 
way influence generation of the receptor repertoire  (16) of the T-cell clone(s) 
associated with H-2D  b. The second is that helper T cells operating at I-A  b, but 
not at I-A  k, function to facilitate the cytotexic T-cell response associated with H- 
2D  b (17, 18). The latter seems more likely to be true. Normal spleen and lymph 
node cells from (A/J  x  B6) F1 mice can be stimulated to generate cytotoxic T 
cells at H-2D  b when exposed to vaccinia virus in an irradiated B6, but not in a 
B10.A(4R) recipient (Table V). These F1 responder T cells can thus functionally 
interact with vaccinia virus in the context of H-2D  b, but cannot be stimulated in 
a KkI-AkD  b environment. This experiment also shows that the defect associated 
with K k and I-A  k is recessive, a  point which we could not otherwise establish 
with the available target cells. 
Discussion 
Secondary influenza-immune T-cell responses, which may be specific for the 
shared M protein determinant (5-7),  exhibit the same H-2 restriction spectrum 
found previously for other virus systems (19). The total absence of responsive- 
ness associated with H-2K  b is, however, unique for the conventional infectious 
viruses studied so far (20), though similar phenomena have been described for 
the murine tumor viruses and for the male H-Y antigen (21-23).  Little can be 
said concerning the possible mechanism, as we do not know whether there is a P.  C.  DOHERTY,  W.  E.  BIDDISON,  J.  R.  BENNINK,  AND  B.  B.  KNOWLES 
TABLE V 
Stimulation ofF1 Lymphocytes with Vaccinia Virus in  Parental or  BI  O.A(4R) 
Recipients 
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Specific slCr release (50:1)$ 
Transferred pop-  Irradiated re- 
L Cell (kk)  MC57G  (bb)  2RSV (kb)  5RSV (bd)  ulation*  cipient 
Inf.  N  Inf.  N  Inf.  N  Inf.  N 
% 
(A/J x B6) F1  B6  22  21  73  0  64  13  68  0 
(Kk-D  d x  A/J  83  21  6  0  61  14  58  0 
Kb-D  b)  B10.A(4R)  81  16  15  6  66  7  0  0 
* Mice were irradiated (950 rads),  given 6.0 × i0  )  spleen and lymph node cells  i.v.  18 h later  and 
dosed i.v.  with vaccinia  virus after  an additional 3 h. 
* Target cells  were either infected  with vaccinia  virus (Inf.)  or uninfected (N). 
defect in the T-cell receptor repertoire or if antigen is presented in an inadequate 
way. Evidence to support the latter idea is available from the Friend leukemia 
model, where H-2 gene products associated with responsiveness are selectively 
incorporated into the virion (21). 
In either case,  the existence of such a  defect associated with a  potentially 
lethal  (and  highly contagious)  virus  disease  strengthens earlier  speculation 
that infectious processes have exerted major pressures on the evolution of H- 
gene polymorphism (24). Both heterozygosity at a particular H-2 locus, and the 
existence of a duplicated system at H-2K and H.2D, would operate to minimize 
the possibility of a total lack of T-cell responsiveness to any given virus. Such a 
concept is, as pointed out before (19), equally valid for altered-self and for dual 
recognition models. 
Earlier  experiments with  ectromeli'a virus,  which  (unlike  influenza)  is  a 
major cause  of disease  in  laboratory mice,  failed to  detect  any H-2-related 
failure  in  T-cell  responsiveness  (10, 20). Alleles  associated  with  defective 
response  may  thus  have  been  selected  out.  Wild  mice  normally  exist  in 
environmentally restricted "demes," that exhibit a much more limited range of 
H-2 types than is recognized for the species as a whole (25). Endemic infectious 
processes may also observe distinct boundaries for susceptible species that live 
in close proximity but have little real contact as documented, for instance, for 
leptospirosis  in the  Malayan rain forest  (26). Selection may thus operate to 
maximize  the  frequency  of genes  associated  with  resistance  to  the  set  of 
pathogens encountered commonly in a particular environmental niche. A novel 
pandemic may eliminate some  demes,  but  leave  many intact.  Selection for 
polymorphism would thus operate at the total population level. The situation 
for  a  more  widely  ranging  species,  such  as  man,  may  be  quite  different. 
Evolutionary pressures may favor heterozygosity, and thus polymorphism, in 
the population at large (24). 
The  absence  of  significant  virus-immune  T-cell  generation  at  H-2D  b  in 
B10.A(4R)  (kkbbbb)  but not in B10  (bbbbbb)  mice probably represents an Ir- 
gene effect, similar to those described for responses to trinitrophenyl-modified 
cells and to the male Y antigen (22, 27). The H-2 recombinants necessary for 540  H-2-RELATED  LOW  RESPONSIVENESS  OF  VIRUS-IMMUNE  T  CELLS 
distinguishing  whether  the K  or the I-A  locus  is  involved  do  not yet exist. 
However,  the  phenomenon  is  seen  for  both the  infectious  processes studied. 
These  systems differ in  that  mice  primed  with  vaccinia  virus,  but  not  with 
influenza virus, generate a  strong cytotoxic T-cell response associated with H- 
2K  b.  It  thus  seems likely that  any collaboration  between proliferating  T-cell 
subsets (17, 18) would involve LA  b rather than K b. 
Exposure to vaccinia virus leads to generation of potent effector T cells at K k 
but  not  at  D  b  in  the  B10.A(4R)  environment,  even  when  the  lymphocyte 
population  stimulated  (A/J  ×  B6) F1  is capable of responding  at  D b in  a  B6 
recipient and the relevant antigen  is expressed on B10.A(4R) target cells. The 
defect is thus  in  the  capacity to stimulate.  Two quite  different  explanations 
may be proposed. One possibility is that the T-cell operating at D  b has receptors 
for both LA  b and D  b, as well as for viral antigen,  and all of these are required 
for induction of the response but only the latter two are necessary for mediating 
cytotoxic effector function. The Ia in question may be expressed on macrophages 
or on a secreted factor (28). 
The  alternative  idea  that  T-T  help  (17,  18)  is  involved  raises  questions 
concerning  the  specificity  of  the  helper  T-cell  subset.  The  vaccinia-  (and 
influenza-) immune T-cell response at K k is potent in the B10.A(4R). Thus, ifT- 
T  help  is  mandatory  for  all  cytotoxic  T-cell  responses  (17,  18),  a  helper 
population exists which can facilitate generation of effector T cells at K k but not 
at D  b. How might such discrimination operate? 
One possibility is that the helper T cells are recognizing idiotype. However, 
the  non-H-2  genetic  background  is  the  same  for  B10.A(4R)  and  B10  so the 
lymphocyte receptor idiotypes (29,  30) specific for viral components should be 
identical  for  cytotoxic T  cells  functioning  at  K k,  K b,  and  D  b,  unless  we  are 
considering recognition of distinct altered-self structures. Perhaps helper T cells 
which interact with the self-recognition component operating at K k, but not at 
D  b, are generated in the context ofI-A  k. This would explain why theresponse to 
both influenza  and vaccinia viruses is depressed.  A  further possibility is that 
the helper T cell shows specificity for Ia determinants which are expressed on 
the virus-immune  population functioning at K k but not at D  b. We know of no 
information concerning such an exclusion of Ia presentation on T-cell subsets. 
However, the presence of I-region antigens on thymus-derived lymphocytes is 
now established (31), and helpers and suppressors are known to express I-A and 
I-J coded components, respectively (32). 
Summary 
Secondary effector T-cell populations generated by cross-priming with heter- 
ologous influenza A viruses operate only in H-2K or H-2D compatible situations, 
when  assayed  on  SV40-transformed  target  cells  infected  with  a  range  of 
influenza A  viruses.  The H-2K  b allele is associated with a  total failure in the 
generation of influenza-immune cytotoxic T cells, though this is not seen for the 
primary response to vaccinia virus. In both influenza and vaccinia development 
of effector T cells operating at H-2D  b is greatly depressed in B10.A(2R) (kkkddb) 
and B10.A(4R) (kkbbbb), but not in B10 (bbbbbb), mice. However, there is no 
defect in viral antigen expression at either H-2K  k or H-2D  b in B10.A(2R) target P,  C.  DOHERTY~  W.  E.  BIDDISON~  J.  R.  BENNINK~ AND  B.  B.  KNOWLES  541 
cells. This apparently reflects some inadequacy in the stimulator environment, 
as (AJJ  ×  B6) F1 T  cells can be induced to respond at H-2D  b when exposed to 
vaccinia virus in an irradiated B6 but not in a B10.A(4R) recipient. The present 
report, together with the accompanying paper by Zinkernagel and colleagues, 
records the first rigorous demonstration of both a nonresponder situation and a 
probable Ir-gene effect for conventional infectious viruses. Possible implications 
for the evolution of H-2 polymorphism and mechanisms oflr gene function are 
discussed. 
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